Exact Sciences to Acquire Ashion Analytics

Exact Sciences Corp. (Nasdaq: EXAS) announced Tuesday that it has entered into an agreement to acquire Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope. Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments.

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently introduced Bigfoot Spectral Cell Sorter and approximately 40 employees will become part of Thermo Fisher’s Biosciences business. Propel Labs will continue to operate as a separate entity and serve its existing customers.

HORIBA Acquires MedTest DX and Pointe Scientific to Expand Laboratory Chemistry Offerings

HORIBA, Ltd. (Headquarters in Kyoto, Japan, referred to as HORIBA) and HORIBA Instruments (Headquarters in Irvine, California) announced Tuesday that it has acquired MedTest Holdings, Inc. (Headquarters in Canton, MI, USA, composed of MedTest Dx, Inc., Pointe Scientific, Inc., Clinitox Diagnostix, Inc., and Medical Laboratory Solutions, Inc.). The acquisition will combine the complimentary innovative technology offerings of the HORIBA Medical segment (referred to as HORIBA Medical) with MedTest Dx technology, Clinitox, and Pointe Scientific’s R&D and manufacturing capabilities, with particular expertise in FDA 510K and CLIA clearances, to address the multidisciplinary requirements of IVD1 testing customers.

Charles River Laboratories Acquires Distributed Bio

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination of an exclusive partnership between these companies that was initiated in October 2018. Based in South San Francisco, California, Distributed Bio is a next-generation antibody discovery company.

Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex

Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research.

Eurofins Transplant Diagnostics Expands Footprint in Hawaii through the Acquisition of Hawaii Cellular Therapy and Transplant Laboratory (HCTTL)

Eurofins’ US Transplant Diagnostics is proud to announce the successful acquisition of the Hawaii Cellular Therapy and Transplant Laboratory (HCTTL). HCTTL will merge with Eurofins VRL, a market leader in US pre-transplant testing, and expand VRL’s substantial US geographic footprint. The addition of this highly regarded and long-standing pillar of the Hawaiian transplant community will further increase VRL’s network of laboratories that are now located in 11 states, serving Organ Procurement Organizations, Tissue Banks, and commercial companies needing testing for donated biological materials.

Thompson Street Capital Partners Announces the Sale of Analytical Lab Group to Element Materials Technology

Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that it has completed the sale of Analytical Lab Group (ALG), an industry-leading microbiology and viral lab, to Element Materials Technology (Element), one of the world’s largest providers of materials and product qualification testing, inspection and certification services to the global aerospace, transportation & industrials, connected technologies, energy, and fire & building products sectors. ALG’s team of 130 scientists and experts operates a number of FDA and EPA compliance focused laboratories in San Francisco, Minneapolis and Boston and has built a strong reputation in the infection prevention market, offering comprehensive testing solutions in the molecular cell biology and virology testing, antimicrobial, pharmaceutical, medical device, biotech and healthcare industries, backed by sound regulatory and scientific expertise.

Dotmatics Acquires BioBright to Accelerate Laboratory Data Automation for the Lab of the Future

Dotmatics Ltd., a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, has today announced that it has entered into an agreement to acquire BioBright LLC, a leader in automating the flow of data from laboratory instruments to a secure cloud. BioBright is a privately-owned scientific lab data automation company based in Boston, MA, dedicated to creating the smart laboratory of the future driven by the move to data-centric research. The company’s solutions enable scientists to automate the collection of data from in-house and externally networked sources, and then standardize and analyze crucial experimental data with validation and integrity checks built in. It began operations in 2015 and was funded early on by the Defense Advanced Research Projects Agency to create a secure data collection platform for complex biological data.

Pfingsten Expands Laboratory Instrumentation Services Platform

Pfingsten announces its portfolio company, Full Spectrum Group, LLC (“FSG”), has acquired the assets of the Third Party Field Service Division of Pion Inc. (“Pion TFPS”), a brand-agnostic provider of repair, maintenance, validation, and qualification services for laboratory instrumentation. Headquartered in Benson, North Carolina, Pion TFPS serves a diverse nationwide customer base in biotechnology, life sciences, pharmaceutical, and other end markets. Pion TFPS represents FSG’s first acquisition since Pfingsten became the majority shareholder in February 2019.

COVID-19 Testing Provider Curative Acquires KorvaLabs

COVID-19 testing startup Curative Inc. announced today that it has completed the acquisition of KorvaLabs, Inc., a CLIA certified and DEA licensed analytical laboratory based in San Dimas, California. The acquisition arrives just months after the two organizations first partnered to begin manufacturing and processing Curative’s oral fluid-based COVID-19 test. To date, the company has processed 245,371 tests in total with support from KorvaLabs, and continues to process approximately 14,000 on a daily basis. “KorvaLabs has been instrumental in enabling us to quickly scale our testing capacity and deliver accurate, easy-to-use oral fluid tests to thousands of people across the City and County of Los Angeles,” said Fred Turner, CEO and founder of Curative. “Curative has worked in close partnership with KorvaLabs for months now, so our decision to move forward with the acquisition just serves to formalize that relationship.”